CNS to commence trial of Berubicin for glioblastoma multiforme

CNS Pharmaceuticals is set to commence its pivotal trial of Berubicin to treat recurrent glioblastoma multiforme (GBM).

Related Keywords

Poland ,Spain ,Spanish ,John Climaco ,Centric Services For ,Electronic Data Capture Solutions For Clinical Trials ,Competent Authority ,Drug Administration ,Health Products ,Children Memorial Health Institute ,Celm Provincial De Sevilla Ethics Committee ,Cns Pharmaceuticals ,Spanish Agency For Medicines ,Spanish Agency ,Provincial De Sevilla Ethics Committee ,Memorial Health Institute ,Regulatory Consultation ,Data Capture Solutions ,Centric Services ,Alternate Site Clinical Trials ,